Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease.
Sangeetha PerumalsamyHasniza Zaman HuriBashar Mudhaffar AbdullahOthman MazlanWan Azman Wan AhmadShireene Ratna D B VethakkanPublished in: Metabolites (2023)
Type 2 diabetes mellitus (T2DM) is characterized by impaired insulin secretion on a background of insulin resistance (IR). IR and T2DM are associated with atherosclerotic coronary artery disease (CAD). The mechanisms of IR and atherosclerosis are known to share similar genetic and environmental roots. Endothelial dysfunction (ED) detected at the earliest stages of IR might be the origin of atherosclerosis progression. ED influences the secretion of pro-inflammatory cytokines and their encoding genes. The genes and their single nucleotide polymorphisms (SNPs) act as potential genetic markers of IR and atherosclerosis. This review focuses on the link between IR, T2DM, atherosclerosis, CAD, and the potential genetic markers CHI3L1 , CD36 , LEPR , RETN , IL-18 , RBP-4 , and RARRES2 genes.
Keyphrases
- genome wide
- coronary artery disease
- insulin resistance
- cardiovascular disease
- dna methylation
- copy number
- glycemic control
- emergency department
- type diabetes
- adipose tissue
- metabolic syndrome
- percutaneous coronary intervention
- genome wide identification
- skeletal muscle
- heart failure
- coronary artery bypass grafting
- cardiovascular risk factors
- gene expression
- aortic valve
- genome wide analysis
- transcatheter aortic valve replacement
- ejection fraction